https://www.intelligence.senate.gov/sites/default/files/documents/CREC-2019-12-17-pt1-PgS7090-3.pdf

China’s Biological Weapons Program. The Committees remain interested in ensuring the Defense Intelligence Enterprise is providing timely, accurate, and effective intelligence to support information needs of the DoD, and are aware of a recent GAO report on long-range emerging threats facing the United States that highlighted potential pursuit by near-peer competitors of biological weapons using genetic engineering and synthetic biology. Therefore, the Committees direct the USD(I), in coordination with the Director of the DIA, to provide a briefing to the congressional intelligence and defense committees within 30 days of enactment of the Act with an assessment of China’s current and projected biological weapons program, the risks presented to the joint force, and the mitigation strategies to protect U.S. military forces against said threats.